NEWCELX LTD
NCELNASDAQ🏆 #4710 by market capUS Equity
$2.37▼ $0.48 (−16.73%)
Pre-market · at closeTrack NCEL
Get earnings, price moves & breaking news on Telegram
24h▼ 16.7%
7d▼ 16.7%
14d▼ 16.7%
30d▼ 21.2%
ytd▲ 16.5%
1y▼ 68.9%
🏦Market Cap
$13M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- $2.37 – $2.37
- 52-Week Range
- $1.83 – $13.60
- Volume (shares)
- 355
- Avg Volume (shares)
- —
- Shares Outstanding
- 5.4M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- —
- Last Q Revenue
- —
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- $-1.33
- Dividend Yield
- —
NEWCELX LTD
NCELFinancial Trends
Financial history unavailable.
StockOtter · stockotter.spaceAbout NEWCELX LTD
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Overall Score
Insufficient data
—/100
Analyst data unavailable.
Latest News & Updates
News unavailable.